Tonix prices $7M public offering of common stock and warrants to fund operations

Tonix Pharmaceuticals Holding Corp.

Priced $7M public offering: 2.53M shares + pre-funded warrants for 4.47M shares + 7M common warrants at $1.00 per unit.
Gross proceeds ~$7M; net proceeds for working capital, facility build-out, and product acquisition/licensing.
Common warrants exercisable at $1.00/share, expire 5 years from issuance.
Lock-up: directors/officers restricted from selling for 60 days post-closing.
Closing expected August 1, 2023; A.G.P. and Brookline Capital Markets acting as placement agents.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tonix Pharmaceuticals Holding Corp. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents") (effective 2023-07-27).

Action: entry
Agreement: underwriting
Counterparty: A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents")
Effective: 2023-07-27

Exact text from the filing

On July 27, 2023, the Company also entered into a placement agent agreement (the "Placement Agent Agreement") with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents").

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tonix Pharmaceuticals Holding Corp. entered into Purchase Agreement with certain institutional investors (the "Purchasers") valued at $1.00 (effective 2023-07-27).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional investors (the "Purchasers")
Value: $1.00
Effective: 2023-07-27

Exact text from the filing

On July 27, 2023, Tonix Pharmaceuticals Holding Corp. (the "Company"), entered into a securities purchase agreement (the "Purchase Agreement") with certain institutional investors (collectively, the "Purchasers").

View on SEC.gov

273 material agreements filed in the last 30 days. Browse all material agreements →

Tonix Pharmaceuticals Holding Corp. filing history →

Source: SEC EDGAR

accession 0001387131-23-009019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.